Drug repurposing against SARS-CoV-2 using computational approaches

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has generated a critical need for treatments to reduce morbidity and mortality associated with this disease. However, traditional drug development takes many years, which is not practical solution given the current pandemic. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sumit, Kovalenko, Svitlana, Bhardwaj, Shakshi, Sethi, Aaftaab, Gorobets, Nikolay Yu., Desenko, Sergey M., Poonam, Rathi, Brijesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Post-Screen (Grey)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830191/
https://www.ncbi.nlm.nih.gov/pubmed/35151891
http://dx.doi.org/10.1016/j.drudis.2022.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830191/
https://www.ncbi.nlm.nih.gov/pubmed/35151891
http://dx.doi.org/10.1016/j.drudis.2022.02.004

Ejemplares similares